
Hard Sell, Evan Hughes
The inside story of a band of entrepreneurial upstarts who made millions selling painkillers—until their scheme unraveled, putting them at the center of a landmark criminal trial.
La minimul din 30 de zileCel mai bun preț din fiecare magazin
| Magazin | Preț | Istoric | |
|---|---|---|---|
AN Anticexlibris ISBN 9780385544900 |
29,99 lei | minim aici: 16,98 lei | Vezi în magazin |
Prețurile sunt preluate automat din feed-urile magazinelor și pot varia; prețul valabil este cel din magazin, la finalizarea comenzii. Linkurile către magazine sunt linkuri de parteneriat — nu îți schimbă prețul și nu influențează ordinea ofertelor.
Evoluția prețului
Ce arată măsurătorile noastre
- Cel mai mic preț înregistrat de noi
- 16,98 lei
- Cel mai mare preț înregistrat
- 29,99 lei
- Preț mediu în perioada monitorizată
- 23,49 lei
- Zile de când îl urmărim
- 3
- Schimbări de preț înregistrate
- 2 (2 în ultimele 30 de zile)
Toate cifrele de mai sus sunt calculate exclusiv din prețurile pe care le-am înregistrat noi, zilnic, de la magazinele monitorizate.
Graficul arată cel mai mic preț disponibil în fiecare zi, între toate magazinele monitorizate. Linia verde este minimul din ultimele 30 de zile.
Îți trimitem un e-mail când prețul scade sub 16,98 lei. Îți cerem o confirmare pe e-mail înainte de a-ți trimite orice alertă și te poți dezabona oricând.
Despre acest produs
The inside story of a band of entrepreneurial upstarts who made millions selling painkillers—until their scheme unraveled, putting them at the center of a landmark criminal trial. “A fast-paced and maddening account. Until I read The Hard Sell, about the outrageous behavior of an obscure drug company, I hadn’t appreciated the full extent of the filth or the dark stain the opioid sector has left on the entire industry. What’s most surprising and powerful about The Hard Sell is not one company’s criminality—we’ve grown inured to corporations behaving badly—as much as how institutionalized these practices were across the modern drug industry.” —New York Times Book Review John Kapoor had already amassed a small fortune in pharmaceuticals when he founded Insys Therapeutics. It was the early 2000s, a boom time for painkillers, and he developed a novel formulation of fentanyl, the most potent opioid on the market. Kapoor, a brilliant immigrant scientist with relentless business instincts, was eager to make the most of his innovation. He gathered around him an ambitious group of young lieutenants. His head of sales—an unstable and unmanageable leader, but a genius of persuasion—built a team willing to pull every lever to close a sale, going so far as to recruit an exotic dancer ready to scrape her way up. They zeroed in on the eccentric and suspect doctors receptive to their methods. Employees at headquarters did their part by deceiving insurance companies. The drug was a niche product, approved only for cancer patients in dire condition, but the company’s leadership pushed it more widely, and together they turned Insys into a Wall Street sensation. But several insiders reached their breaking point and blew the whistle. They sparked a sprawling investigation that would le
Descriere preluată din fișa produsului de la Anticexlibris.
Produse similare din Business & economie
Vezi categoria →










